Innovative Medical Technology

Neurotron, Incorporated

   Innovative Medical Technology

                 Established 1981

Neurometer® sNCT Electrodiagnostic Evaluation Professional Responsibilities

 Patient Care


 Press Releases






 Clinical Apps







 The clinical judgment of a licensed doctor is required and appropriate to determine if a patient's symptoms and physical examination merit an sNCT evaluation. The doctor must prescribe the evaluation including the body sites to be tested according to his/her differential diagnosis. Trained (non physician) personnel may perform the test procedure. A clinician's impression should accompany the software generated analysis of the sNCT test results. The neurophysiologic data from the tests should be maintained in the patient's medical record.

The manufacturer's recommended procedural guidelines must be followed to allow reproducible automated sNCT generated CPT values to be obtained in a standardized double blind fashion with a resolution of +/- 20
µAmperes (p<0.006) and to permit the detection of patient non-compliance.

It recommended that the clinician document why the sNCT evaluation is indicated, the interpretation of the sNCT test results and how the sNCT findings will affect the patient's management. Reasons for a repeat study, including a comparison with the previous test results, must also be documented.

This examination is a prescription procedure that may only be preformed by or on the order of a licensed healthcare professional. The sNCT evaluation provides the clinician with a means to obtain an objective quantitative differential diagnosis of sensory nerve impairments and to assess and document the efficacy of therapeutic intervention.

 Inappropriate Use of the sNCT™ Evaluation Includes the Following:
 1.  Indiscriminate testing of patients without a complete physical examination and documentation of sensory abnormalities

 2.  Testing patients without documented suspected sensory impairments.

 3.  Testing patients without establishing and documenting why the test is indicated.

 4.  Testing an excessive number of sites beyond those necessary to determine a differential diagnosis including, with rare exceptions, testing for both an upper and a lower extremity radiculopathy at the same time on the same patient.

 5.  Conducting the sNCT evaluation and not incorporating the test result findings into the patient's management.
 6.  Repeat testing of patients without an examination and documentation of a change in sensory abnormalities or an equivocal response to a therapeutic intervention.
 7.  Testing which is not reasonable or necessary to diagnose or treat an illness or injury or evaluate to a clinically equivalent response to a therapeutic intervention.

top of page      Previous page     Home



The entire contents of this web site are Copyright 1996-2010, Neurotron, Incorporated

Est. 1981, Baltimore, MD, USA.  All rights reserved, worldwide

rev 01/07/10